Veristat is a specialty Contract Research Organization (CRO) that offers comprehensive clinical trial and consulting services. Particularly focused on the pharmaceutical and biotechnology sectors, Veristat supports their clients' development and regulatory strategy for complex and novel therapies. The company's expertise spans biologics, gene therapies, rare diseases, and regulatory submissions. Their services include full-service clinical trial planning, clinical trial conduct, and regulatory affairs, with a strong emphasis on adaptive designs, biostatistics, and pharmacovigilance. Veristat has been pivotal in advancing therapies through strategic consulting and clinical operations, from oncology and neurology to infectious diseases.